Heron Therapeutics (United States)

Cost-Effectiveness Analyses of Natalizumab (Tysabri®) Compared with Other Disease-Modifying Therapies for People with Highly Active Relapsing-Remitting Multiple Sclerosis in the UK

Ray Gani, Gavin Giovannoni, David O. Bates et al. · PharmacoEconomics · 2008 · 103 citations

Disease Management, Clinical Effectiveness, Other Disease-modifying Therapies +7

Applying Model Based Systems Engineering (MBSE) to a standard CubeSat

Sara Spangelo, David Kaslow, Christopher Delp et al. · 2012 · 103 citations

Engineering, Modeling Method, Software Engineering +20

Cardiopulmonary Bypass Induces Release of Soluble CD40 Ligand

Lisa Nannizzi‐Alaimo, Mark H. Rubenstein, Veronica L. Alves et al. · Circulation · 2002 · 80 citations · Full text

Food chain analysis of exposures and risks to wildlife at a metals-contaminated wetland

Gary A. Pascoe, Richard J. Blanchet, G. Linder · Archives of Environmental Contamination and Toxicology · 1996 · 58 citations

Ecotoxicity, Food Chain Analysis, Environmental Health +8

HTX-011 reduced pain intensity and opioid consumption versus bupivacaine HCl in bunionectomy: phase III results from the randomized EPOCH 1 study

Eugene R. Viscusi, Joseph Gimbel, Richard A Pollack et al. · Regional Anesthesia & Pain Medicine · 2019 · 52 citations · Full text